
Last updated: 2 months ago
Pfizer vs. Novo Nordisk: The Obesity Drug Showdown
Explore the fierce competition in the obesity drug market as Pfizer challenges Novo Nordisk's dominance. Key insights on market dynamics, drug development, and investment potential.



